Menopausal hormone therapy increases breast cancer risk for years | University of Oxford

An international collaboration, using data from more than 100,000 women with breast cancer from 58 epidemiological studies worldwide, has found that using menopausal hormone therapy (MHT) is associated with an increased risk of breast cancer, and that some increased risk persists for more than a decade after use stops.


This site uses cookies and analysis tools to improve the usability of the site. More information. |